The “Dual-Pathway” Strategy after Acute Coronary Syndrome: Rivaroxaban and Antiplatelet Agents in the ATLAS ACS 2-TIMI 51 Trial

Acute coronary syndrome (ACS) is a medical emergency often associated with an occlusive coronary event with consequent myocardial underperfusion. Patients require immediate antiplatelet therapy and long-term antithrombotic prophylaxis to reduce the risk of recurrence. Acetylsalicylic acid (ASA) alon...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Marc, Iyer, Deepa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285947/
https://www.ncbi.nlm.nih.gov/pubmed/24894120
http://dx.doi.org/10.1111/1755-5922.12083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285947/
https://www.ncbi.nlm.nih.gov/pubmed/24894120
http://dx.doi.org/10.1111/1755-5922.12083

Ejemplares similares